Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer.

Antonella Palazzo,Silvia Dellapasqua,Elisabetta Munzone,Vincenzo Bagnardi,Manuelita Mazza,Giuseppe Cancello,Raffaella Ghisini,Monica Iorfida,Emilia Montagna,Aaron Goldhirsch,Marco Colleoni

Clinical Breast Cancer（2018）

引用 13|浏览53

暂无评分

摘要

In patients with IBC, neoadjuvant treatment with the investigated regimen was successful and well tolerated. Further studies evaluating the potential benefit of an antiangiogenic strategy in this setting are awaited.

查看译文

关键词

Antiangiogenesis,IBC,Metronomic chemotherapy,Neoadjuvant chemotherapy,Outcome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要